cilostazol has been researched along with escitalopram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdallah, MS; Abo Mansour, HE; Elsawah, HK; Elsokary, MA; Mansour, NO; Mosalam, EM; Omara-Reda, H; Ramadan, AN; Zaki, SA | 1 |
1 review(s) available for cilostazol and escitalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cilostazol and escitalopram
| Article | Year |
|---|---|
Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.
Topics: Adult; Cilostazol; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Escitalopram; Female; Humans; Inflammation; Male; Middle Aged; Outcome Assessment, Health Care; Phosphodiesterase 3 Inhibitors; Pilot Projects; Selective Serotonin Reuptake Inhibitors | 2021 |